1. Drug delivery
Method or process of administering a pharmaceutical compound to achieve a therapeutic effect. 2. Metered Dose Inhaler
Device that helps deliver a specific amount of medication to the lungs, usually by supplying a short burst of aerosolized medicine that is inhaled by the patient. It is commonly used to treat asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. A Metered Dose Inhaler consists of two major components: the canister or can and the actuator (or mouthpiece). 3. Canisters/cans
Deep drawn components manufactured from aluminium or stainless steel to carry the medication. Presspart manufactures thick wall coated, thick wall uncoated and thin wall uncoated cans. 4. Actuator
The actuator, which is injection moulded out of polypropylene, contains the discharge nozzle and generally includes a dust cap to prevent contamination. Actuation of the device releases a single metered dose of liquid propellant that contains the medication. 5. Valve components
Device that regulates the flow of materials (gases, fluidized solids, slurries, or liquids) by opening, closing or partially obstructing various passage ways. 6. Respiratory diseases
Term for diseases of the respiratory system. These include diseases of the lung, pleural cavity, bronchial tubes, trachea, upper respiratory tract and of the nerves and muscles of breathing. 7. Asthma
Asthma is a chronic condition involving the respiratory system in which the airways occasionally constrict, become inflamed, and are lined with excessive amounts of mucus. 8. Chronic Obstructive Pulmonary Disease (COPD)
COPD is a disease of the lungs in which the airways become narrowed. This limits the flow of air to and from the lungs causing shortness of breath. In contrast to asthma, the limitation of airflow is poorly reversible and usually gets gradually worse over time. 9. Pharmaceutical Packaging
Pharmaceutical packaging comprises different packaging materials interacting with the medical drug. The principal pack material for pharmaceutical packaging is plastic. 10. Chlorofluorocarbons (CFC)
One major use of CFCs has been as propellants in aerosol inhalers for drugs used to treat asthma. Their use has been regularly prohibited by the Montreal Protocol, because of effects on the ozone layer. As of January 1, 2010, CFCs will be banned as excipients in manufacturing inhalant aerosols. 11. Hydrofluoroalkane (HFA)
The propellant HFA was developed to replace chlorofluorocarbon (CFC).
Method or process of administering a pharmaceutical compound to achieve a therapeutic effect. 2. Metered Dose Inhaler
Device that helps deliver a specific amount of medication to the lungs, usually by supplying a short burst of aerosolized medicine that is inhaled by the patient. It is commonly used to treat asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. A Metered Dose Inhaler consists of two major components: the canister or can and the actuator (or mouthpiece). 3. Canisters/cans
Deep drawn components manufactured from aluminium or stainless steel to carry the medication. Presspart manufactures thick wall coated, thick wall uncoated and thin wall uncoated cans. 4. Actuator
The actuator, which is injection moulded out of polypropylene, contains the discharge nozzle and generally includes a dust cap to prevent contamination. Actuation of the device releases a single metered dose of liquid propellant that contains the medication. 5. Valve components
Device that regulates the flow of materials (gases, fluidized solids, slurries, or liquids) by opening, closing or partially obstructing various passage ways. 6. Respiratory diseases
Term for diseases of the respiratory system. These include diseases of the lung, pleural cavity, bronchial tubes, trachea, upper respiratory tract and of the nerves and muscles of breathing. 7. Asthma
Asthma is a chronic condition involving the respiratory system in which the airways occasionally constrict, become inflamed, and are lined with excessive amounts of mucus. 8. Chronic Obstructive Pulmonary Disease (COPD)
COPD is a disease of the lungs in which the airways become narrowed. This limits the flow of air to and from the lungs causing shortness of breath. In contrast to asthma, the limitation of airflow is poorly reversible and usually gets gradually worse over time. 9. Pharmaceutical Packaging
Pharmaceutical packaging comprises different packaging materials interacting with the medical drug. The principal pack material for pharmaceutical packaging is plastic. 10. Chlorofluorocarbons (CFC)
One major use of CFCs has been as propellants in aerosol inhalers for drugs used to treat asthma. Their use has been regularly prohibited by the Montreal Protocol, because of effects on the ozone layer. As of January 1, 2010, CFCs will be banned as excipients in manufacturing inhalant aerosols. 11. Hydrofluoroalkane (HFA)
The propellant HFA was developed to replace chlorofluorocarbon (CFC).